Literature DB >> 29545420

Endovascular recanalisation with drug coated balloon for chronic symptomatic middle cerebral artery total occlusion.

Jun Zhang1, Xiao Zhang1, Jin-Ping Zhang1, Ju Han1.   

Abstract

The optimal treatment for patients with chronic symptomatic middle cerebral artery (MCA) total occlusion is not well established. In addition to medical therapy, vessel recanalisation with stenting has shown much promise, especially for patients with recurrent ischemic symptoms. Nevertheless, the incidence of symptomatic in-stent restenosis (ISR) is high, and is associated with an unfavorable prognosis. Drug coated balloons (DCBs) have been proven to be effective in treating and preventing ISR. However, the feasibility of DCBs for de novo intracranial atherothrombotic stenosis has not been previously described, especially for total occlusion lesions. Here we reported a patient with chronic left MCA total occlusion successfully treated with DCBs, with a good outcome at the 1 year follow-up. More studies are warranted to further compare the efficacy of DCBs and stentings for intracranial revascularisation. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  angioplasty; balloon; stenosis

Mesh:

Year:  2018        PMID: 29545420      PMCID: PMC5878401          DOI: 10.1136/bcr-2017-013693

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  How to use the drug-eluting balloon: recommendations by the German consensus group.

Authors:  Franz X Kleber; Detlef G Mathey; Harald Rittger; Bruno Scheller
Journal:  EuroIntervention       Date:  2011-05       Impact factor: 6.534

2.  Neurovascular in-stent stenoses: treatment with conventional and drug-eluting balloons.

Authors:  Z Vajda; T Güthe; M Aguilar Perez; A Heuschmid; E Schmid; H Bäzner; H Henkes
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-01       Impact factor: 3.825

3.  Efficacy and Safety of Paclitaxel-Coated Balloon for the Treatment of In-Stent Restenosis in High-Risk Patients.

Authors:  Marco Miglionico; Fabio Mangiacapra; Annunziata Nusca; Domenico Scordino; Paolo Gallo; Marco Campanale; Rosetta Melfi; Germano Di Sciascio
Journal:  Am J Cardiol       Date:  2015-09-10       Impact factor: 2.778

4.  Chronic hemodynamic compromise and cerebral ischemic events in asymptomatic or remote symptomatic large-artery intracranial occlusive disease.

Authors:  H Yamauchi; T Higashi; S Kagawa; Y Kishibe; M Takahashi
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-07       Impact factor: 3.825

Review 5.  Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier.

Authors:  Philip B Gorelick; Ka Sing Wong; Hee-Joon Bae; Dilip K Pandey
Journal:  Stroke       Date:  2008-06-05       Impact factor: 7.914

6.  Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.

Authors:  Bruno Scheller; Christoph Hehrlein; Wolfgang Bocksch; Wolfgang Rutsch; Dariush Haghi; Ulrich Dietz; Michael Böhm; Ulrich Speck
Journal:  Clin Res Cardiol       Date:  2008-06-05       Impact factor: 5.460

7.  Endovascular revascularization of symptomatic chronic middle cerebral artery occlusions: Two case reports.

Authors:  Yue Wan; Wai-Ting Lo; Yang-Xia Liu; Xiao-Xiang Peng
Journal:  Interv Neuroradiol       Date:  2015-12-07       Impact factor: 1.610

8.  Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis.

Authors:  Bruno Scheller; Ulrich Speck; Claudia Abramjuk; Ulrich Bernhardt; Michael Böhm; Georg Nickenig
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

9.  Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion.

Authors:  Ning Ma; Da-Peng Mo; Feng Gao; Zhong-Rong Miao
Journal:  J Neurointerv Surg       Date:  2012-04-11       Impact factor: 5.836

10.  Prevention of intracranial in-stent restenoses: predilatation with a drug eluting balloon, followed by the deployment of a self-expanding stent.

Authors:  Zsolt Vajda; Thomas Güthe; Marta Aguilar Perez; Wiebke Kurre; Elisabeth Schmid; Hansjörg Bäzner; Hans Henkes
Journal:  Cardiovasc Intervent Radiol       Date:  2012-08-07       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.